267
Views
0
CrossRef citations to date
0
Altmetric
Review Article

Nutritional modulation of the “brain–;gut axis”

, MD PhD
Pages 98-105 | Received 19 May 2005, Accepted 23 May 2005, Published online: 13 Dec 2016

References

  • TalleyNJ, SpillerR. Irritable bowel syndrome: a little understood organic bowel disease? Lancet 2002 360 555–64.
  • ThompsonWG, LongstrethGF, DrossmanDA, HeatonKW, IrvineEJ, Muller-LissnerSA. Functional bowel disorders and functional abdominal pain Gut 1999 45 Suppl 2 II43–7
  • AzpirozF. Hypersensitivity in functional gastrointestinal disorders Gut 2002 51 Suppl 1 i25–8
  • DelvauxM. Role of visceral sensitivity in the pathophysiology of irritable bowel syndrome Gut 2002 51 Suppl 1 i67–71
  • MertzH. Review article: visceral hypersensitivity Aliment Pharmacol Ther 2003 17 623–33
  • RingelY, SperberAD, DrossmanDA. Irritable bowel syndrome Annu Rev Med 2001 52 319–38
  • MayerEA, GebhartGF. Basic and clinical aspects of visceral hyperalgesia Gastroenterology 1994 107 271–93
  • WalkerEA, Roy-ByrnePP, KatonWJ, LiL, AmosD, JiranekG. Psychiatric illness and irritable bowel syndrome: a comparison with inflammatory bowel disease Am J Psychiatry 1990 147 1656–61
  • DunlopSP, JenkinsD, NealKR, SpillerRC. Relative importance of enterochromaffin cell hyperplasia, anxiety, and depression in postinfectious IBS Gastroenterology 2003 125 1651–9
  • NoyesR Jr, CookB, GarveyM, SummersR. Reduction of gastrointestinal symptoms following treatment for panic disorder Psychosomatics 1990 31 75–9
  • WalkerEA, KatonWJ, JemelkaRP, Roy-BrynePP. Comorbidity of gastrointestinal complaints, depression, and anxiety in the Epidemiologic Catchment Area (ECA) Study Am J Med 1992 92 1A 26–30S
  • ZaublerTS, KatonW. Panic disorder and medical comorbidity: a review of the medical and psychiatric literature Bull Menninger Clin 1996 60 2 Suppl A A12–38
  • LydiardRB. Anxiety and the irritable bowel syndrome: psychiatric, medical, or both? J Clin Psychiatry 1997;58 Suppl 3:51–8; Discussion 59–61
  • KilkensTO, HonigA, RozendaalN, Van NieuwenhovenMA, BrummerRJ. Systematic review: serotonergic modulators in the treatment of irritable bowel syndrome – influence on psychiatric and gastrointestinal symptoms Aliment Pharmacol Ther 2003 17 43–51
  • TyceGM. Origin and metabolism of serotonin J Cardiovasc Pharmacol 1990 16 Suppl 3 S1–7
  • LambertGW, KayeDM, CoxHS, VazM, TurnerAG, JenningsGL Regional 5-hydroxyindoleacetic acid production in humans Life Sci 1995 57 255–67
  • Da PradaM, TranzerJP, PletscherA. Storage of 5-hydroxytryptamine in human blood platelets Experientia 1972 28 1328–9
  • CreedF, FernandesL, GuthrieE, PalmerS, RatcliffeJ, ReadN The cost-effectiveness of psychotherapy and paroxetine for severe irritable bowel syndrome Gastroenterology 2003 124 303–17
  • JacksonJL, O'MalleyPG, TomkinsG, BaldenE, SantoroJ, KroenkeK. Treatment of functional gastrointestinal disorders with antidepressant medications: a meta-analysis Am J Med 2000 108 65–72
  • ClouseRE. Antidepressants for irritable bowel syndrome Gut 2003 52 598–9
  • KimDY, CamilleriM. Serotonin: a mediator of the brain–gut connection Am J Gastroenterol 2000 95 2698–709
  • KilkensTO, HonigA, van NieuwenhovenMA, RiedelWJ, BrummerRJ. Acute tryptophan depletion affects brain–gut responses in irritable bowel syndrome patients and controls Gut 2004 53 1794–800
  • PardridgeWM. Blood–brain barrier carrier-mediated transport and brain metabolism of amino acids Neurochem Res 1998 23 635–44
  • O'KaneRL, HawkinsRA. Na+-dependent transport of large neutral amino acids occurs at the abluminal membrane of the blood–brain barrier Am J Physiol Endocrinol Metab 2003 285 E1167–73
  • RiedelWJ, SobczakS, SchmittJA. Tryptophan modulation and cognition Adv Exp Med Biol 2003 527 207–13
  • MarkusCR, PanhuysenG, TuitenA, KoppeschaarH, FekkesD, PetersML. Does carbohydrate-rich, protein-poor food prevent a deterioration of mood and cognitive performance of stress-prone subjects when subjected to a stressful task? Appetite 1998 31 49–65
  • SmitsKM, SmitsLJ, SchoutenJS, StelmaFF, NelemansP, PrinsMH. Influence of SERTPR and STin2 in the serotonin transporter gene on the effect of selective serotonin reuptake inhibitors in depression: a systematic review Mol Psychiatry 2004 9 433–41
  • CamilleriM. Is there a SERT-ain association with IBS? Gut 2004 53 1396–9
  • ZhangX, GainetdinovRR, BeaulieuJM, SotnikovaTD, BurchLH, WilliamsRB Loss-of-function mutation in tryptophan hydroxylase-2 identified in unipolar major depression Neuron 2005 45 11–6
  • CarrascoGA, Van de KarLD. Neuroendocrine pharmacology of stress Eur J Pharmacol 2003 463 235–72
  • RaapDK, Van de KarLD. Selective serotonin reuptake inhibitors and neuroendocrine function Life Sci 1999 65 1217–35
  • SantosJ, SaperasE, NogueirasC, MourelleM, AntolinM, CadahiaA Release of mast cell mediators into the jejunum by cold pain stress in humans Gastroenterology 1998 114 640–8
  • TacheY, MartinezV, MillionM, WangL. Stress and the gastrointestinal tract III. Stress-related alterations of gut motor function: role of brain corticotropin-releasing factor receptors Am J Physiol Gastrointest Liver Physiol 2001 280 G173–7
  • SöderholmJD, PerdueMH. Stress and gastrointestinal tract. II. Stress and intestinal barrier function Am J Physiol Gastrointest Liver Physiol 2001 280 G7–13
  • MonnikesH, TebbeJJ, HildebrandtM, ArckP, OsmanoglouE, RoseM Role of stress in functional gastrointestinal disorders. Evidence for stress-induced alterations in gastrointestinal motility and sensitivity Dig Dis 2001 19 201–11
  • RaithelM, WinterkampS, PacurarA, UlrichP, HochbergerJ, HahnEG. Release of mast cell tryptase from human colorectal mucosa in inflammatory bowel disease Scand J Gastroenterol 2001 36 174–9
  • VergnolleN, BunnettNW, SharkeyKA, BrusseeV, ComptonSJ, GradyEF Proteinase-activated receptor-2 and hyperalgesia: a novel pain pathway Nat Med 2001 7 821–6
  • BielefeldtK, OzakiN, GebhartGF. Role of nerve growth factor in modulation of gastric afferent neurons in the rat Am J Physiol Gastrointest Liver Physiol 2003 284 G499–507
  • MayerEA, NaliboffBD, ChangL, CoutinhoSV. V. Stress and irritable bowel syndrome Am J Physiol Gastrointest Liver Physiol 2001 280 G519–24
  • BarbaraG, StanghelliniV, De GiorgioR, CremonC, CottrellGS, SantiniD Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome Gastroenterology 2004 126 693–702
  • MarkusCR, OlivierB, PanhuysenGE, Van Der GugtenJ, AllesMS, TuitenA The bovine protein alpha-lactalbumin increases the plasma ratio of tryptophan to the other large neutral amino acids, and in vulnerable subjects raises brain serotonin activity, reduces cortisol concentration, and improves mood under stress Am J Clin Nutr 2000 71 1536–44
  • SubletteME, RussMJ, SmithGS. Evidence for a role of the arachidonic acid cascade in affective disorders: a review Bipolar Disord 2004 6 95–105
  • AnismanH, MeraliZ, PoulterMO, HayleyS. Cytokines as a precipitant of depressive illness: animal and human studies Curr Pharm Des 2005 11 963–72
  • SchiepersOJ, WichersMC, MaesM. Cytokines and major depression Prog Neuropsychopharmacol Biol Psychiatry 2005 29 201–17
  • CollinsSM, VallanceB, BarbaraG, BorgaonkarM. Putative inflammatory and immunological mechanisms in functional bowel disorders Baillieres Best Pract Res Clin Gastroenterol 1999 13 429–36
  • SpillerRC. Inflammation as a basis for functional GI disorders Best Pract Res Clin Gastroenterol 2004 18 641–61
  • GrimbleRF, HowellWM, O'ReillyG, TurnerSJ, MarkovicO, HirrellS The ability of fish oil to suppress tumor necrosis factor alpha production by peripheral blood mononuclear cells in healthy men is associated with polymorphisms in genes that influence tumor necrosis factor alpha production Am J Clin Nutr 2002 76 454–9
  • YoungG, ConquerJ. Omega-3 fatty acids and neuropsychiatric disorders Reprod Nutr Dev 2005 45 1–28
  • NemetsB, StahlZ, BelmakerRH. Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder Am J Psychiatry 2002 159 477–9
  • McEwenBS. Protection and damage from acute and chronic stress: allostasis and allostatic overload and relevance to the pathophysiology of psychiatric disorders Ann N Y Acad Sci 2004 1032 1–7
  • SherL. Type D personality: the heart, stress, and cortisol QJM 2005 98 323–9
  • SongC, KenisG, van GastelA, BosmansE, LinA, de JongR Influence of psychological stress on immune-inflammatory variables in normal humans. Part II. Altered serum concentrations of natural anti-inflammatory agents and soluble membrane antigens of monocytes and T lymphocytes Psychiatry Res 1999 85 293–303
  • MayerEA, CollinsSM. Evolving pathophysiologic models of functional gastrointestinal disorders Gastroenterology 2002 122 2032–48
  • SöderholmJD, StreutkerC, YangPC, PatersonC, SinghPK, McKayDM Increased epithelial uptake of protein antigens in the ileum of Crohn's disease mediated by tumour necrosis factor alpha Gut 2004 53 1817–24
  • MarkovicO, O'ReillyG, FussellHM, TurnerSJ, CalderPC, HowellWM Role of single nucleotide polymorphisms of pro-inflammatory cytokine genes in the relationship between serum lipids and inflammatory parameters, and the lipid-lowering effect of fish oil in healthy males Clin Nutr 2004 23 1084–95
  • HibbelnJR, LinnoilaM, UmhauJC, RawlingsR, GeorgeDT, SalemN Jr. Essential fatty acids predict metabolites of serotonin and dopamine in cerebrospinal fluid among healthy control subjects, and early- and late-onset alcoholics Biol Psychiatry 1998 44 235–42
  • ChalonS, VancasselS, ZimmerL, GuilloteauD, DurandG. Polyunsaturated fatty acids and cerebral function: focus on monoaminergic neurotransmission Lipids 2001 36 937–44
  • WilliamsDL, CummingsDE. Regulation of ghrelin in physiologic and pathophysiologic states J Nutr 2005 135 1320–5
  • BloomS, WynneK, ChaudhriO. Gut feeling – the secret of satiety? Clin Med 2005 5 147–52
  • RehfeldJF. Clinical endocrinology and metabolism. Cholecystokinin Best Pract Res Clin Endocrinol Metab 2004 18 569–86
  • SimrenM, AbrahamssonH, BjörnssonES. An exaggerated sensory component of the gastrocolonic response in patients with irritable bowel syndrome Gut 2001 48 20–7
  • De GiorgioR, CamilleriM. Human enteric neuropathies: morphology and molecular pathology Neurogastroenterol Motil 2004 16 515–31
  • KobayashiH, IshibashiK, NoguchiH. Heart rate variability; an index for monitoring and analyzing human autonomic activities Appl Human Sci 1999 18 53–9
  • FagiusJ. Sympathetic nerve activity in metabolic control – some basic concepts Acta Physiol Scand 2003 177 337–43
  • KleigerRE, SteinPK, BiggerJT Jr. Heart rate variability: measurement and clinical utility Ann Noninvasive Electrocardiol 2005 10 88–101